You're building a house, after all, and you need a solid foundation
Altogether, the Navy investment is $2.9 million, which has resulted in Phase III revenues of $35 million to date, as well as extensive, ongoing, and expanding cost savings and efficiency gains for Navy
Clinical Evidence 2026 Update: Phase 3 TRIUMPH Data In December 2025, Eli Lilly reported the first successful Phase 3 readout for retatrutide (LY3437943) from the TRIUMPH-4 trial
TRT Nations in-depth guide on tirzepatide for women addresses the specific hormonal and metabolic factors that make this population especially responsive to the dual-action mechanism of this medication
However, it is also recognized that levels of this antioxidant normally decline as we age